FOXO3 and metabolic dysfunction-associated steatotic liver disease: miR-421 was suggested to mediate OxS occurrence in NAFLD tissues, based on mice model, by directly targeting SIRT3, thus affecting FOXO3 signaling and leading to decrease of CAT and SOD2 [306].